Elekta
Stock
Stock
ISIN: SE0000163628
Ticker: EKTA B
SE0000163628
EKTA B
Price
Price
CHART BY
Historical dividends and forecast
Elekta has so far distributed $0.119 in 2025. The next dividend will be paid on 12.09.2025
$0.139
CHART BY
Frequently asked questions
What is Elekta's market capitalization?
The market capitalization of Elekta is $2.13B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Elekta's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Elekta is 20.89. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Elekta?
Elekta's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.267. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Elekta's stock?
Currently, 17 analysts cover Elekta's stock, with a consensus target price of $6.534. Analyst ratings provide insights into the stock's expected performance.
What is Elekta's revenue over the trailing twelve months?
Over the trailing twelve months, Elekta reported a revenue of $1.75B.
What is the EBITDA for Elekta?
Elekta's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $252.34M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Elekta?
Elekta has a free cash flow of $209.66M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Elekta have, and what sector and industry does it belong to?
Elekta employs approximately 4,641 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Elekta's shares?
The free float of Elekta is 359.76M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.13B
- EPS (TTM)
- $0.267
- Free Float
- 359.76M
- P/E ratio (TTM)
- 20.89
- Revenue (TTM)
- $1.75B
- EBITDA (TTM)
- $252.34M
- Free Cashflow (TTM)
- $209.66M
Pricing
- 1D span
- $5.443$5.549
- 52W span
- $5.335$8.40
Analyst Ratings
The price target is $6.534 and the stock is covered by 17 analysts.
Buy
5
Hold
6
Sell
6
Information
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America, Europe, Middle East and Africa and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
- Employees
- 4,641
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0000163628
- Primary Ticker
- EKTA B
Knockouts
Finance data from FactSet